Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
uPAR-PET/CT for Prognostication in Head and Neck Cancer
NCT02965001Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2016
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Rigshospitalet. Primary endpoint: Freedom from any failure. Started Nov 2016; status: completed.
Beyond the preview
Go deeper on NCT02965001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965001.